Skip to content

Effect of Kadali vs Apamarga Kshar Therapy in Nasal Blockage Due to Turbinate Swelling

Evaluation of comparative efficacy of Kadali Kshara Pratisarana Nasya versus Apamarga Kshara Pratisarana in the management of Nasapratinaha Inferior Turbinate Hypertrophy Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090643
Enrollment
76
Registered
2025-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J343- Hypertrophy of nasal turbinates

Interventions

None listed

Sponsors

Dr Gauri Ghate
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient having Nasapratinaha(ITH) will be randomly select. Patients above 20 to 80 years of age will be selected. Selection is irrespective of gender, religion & socio economical class. Subjects willing to participate in the study and sign the written informed consent.

Exclusion criteria

Exclusion criteria: Bleeding Disorders (Raktapitta/Nosebleeds - Urdhva Raktapitta) Atrophic Rhinitis (Pootinasa) Nasal polyp Allergic Rhinitis (Vata-Kapha Pratishyaya with hypersensitivity) Nasal Septal Perforation/Ulcers (Nasa Pitta/Vrana). Children & Very Elderly Patients

Design outcomes

Primary

MeasureTime frame
Reduce size of inferior turbinate hypertrophyTimepoint: 6 Weeks

Secondary

MeasureTime frame
Improvement in Total nasal symptoms scoreTimepoint: 6 Weeks

Countries

India

Contacts

Public ContactDr Pramod Borghare

Mahatma Gandhi Ayurved college and research center salod Hirapur Wardha

drpramodborghare@hotmail.com9881225532

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026